Koyfin Home > Directory > Health Care > Revance Therapeutics > Debt Repaid

Revance Therapeutics Debt Repaid Chart (RVNC)

Revance Therapeutics annual/quarterly Debt Repaid from 2012 to 2020.
  • Revance Therapeutics Debt Repaid for the quarter ending June 06, 2020 was $0m a 100.00% decrease of 0m year over year
  • Revance Therapeutics Debt Repaid for the last 12 months ending June 06, 2020 was $-9m a 100.00% decrease of -9m year over year
  • Revance Therapeutics Annual Debt Repaid for 2018 was $-1m a -290.13% increase of 3m from 2017
  • Revance Therapeutics Annual Debt Repaid for 2017 was $-4m a 2.61% decrease of 0m from 2016
  • Revance Therapeutics Annual Debt Repaid for 2016 was $-4m a -48.26% increase of 2m from 2015
Other Cash Flow Metrics:
  • Revance Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-25m a -11.78% increase of 3m year over year
  • Revance Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-14m a -14.44% increase of 2m year over year
  • Revance Therapeutics Total Revenue for the quarter ending September 09, 2018 was $2m a 98.43% increase of 2m year over year
View Chart On Koyfin

Quarterly RVNC Debt Repaid Data

06/2020$0m
03/2020$-9m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$-1m
12/2017$-1m
09/2017$-1m
06/2017$-1m
03/2017$-1m

Annual RVNC Debt Repaid Data

2018$-1m
2017$-4m
2016$-4m
2015$-5m
2014$-13m
2013$-9m
2012$-5m
2011$-13m